Home > Gastroenterology > UEGW 2020 > UEGW Round-Up Articles > Sustained response to faecal microbiota transplantation

Sustained response to faecal microbiota transplantation

Presented By
Prof. Magdy El-Salhy, University of Bergen, Norway
UEGW 2020
  Most IBS patients who responded to faecal microbiota transplantation after 3 months maintained this response at 1 year after the intervention. In this study from Norway, the improvements in symptoms and quality of life increased significantly over time [1]. Sustained changes in the faecal bacteriome and consequent short-chain fatty acid metabolites seemed to associate with better clinical outcomes. A recently published study from Norway showed that faecal microbiota transplantation is an effective and safe treatment for patients with irritable bowel syndrome (IBS) after 3 months [2]. The current follow-up study investigated the efficacy and safety of faecal microbiota transplantation at 1 year after this intervention. The response to faecal microbiota transplantation was maintained at 1 year after treatment in 86.5% and 87.5% of patients who received 30 g and 60 g faecal microbiota transplantation, respectively. In the 30 g fa...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on